{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:14Z","timestamp":1792801454486,"version":"4.5.0"},"reference-count":19,"publisher":"BMJ","issue":"7","funder":[{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Cure Parkinson's Trust"},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CBD Solutions"},{"DOI":"10.13039\/501100023326","name":"Britannia Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100023326","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Association of British Neurologists"},{"DOI":"10.13039\/100013128","name":"MSA Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013128","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008177","name":"Progressive Supranuclear Palsy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008177","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Research Council"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2019,2,11]]},"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The high degree of clinical overlap between atypical parkinsonian syndromes (APS) and Parkinson\u2019s disease (PD) makes diagnosis challenging. We aimed to identify novel diagnostic protein biomarkers of APS using multiplex proximity extension assay (PEA) testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cerebrospinal fluid (CSF) samples from two independent cohorts, each consisting of APS and PD cases, and controls, were analysed for neurofilament light chain (NF-L) and Olink Neurology and Inflammation PEA biomarker panels. Whole-cohort comparisons of biomarker concentrations were made between APS (n=114), PD (n=37) and control (n=34) groups using logistic regression analyses that included gender, age and disease duration as covariates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>APS versus controls analyses revealed 11 CSF markers with significantly different levels in cases and controls (p&lt;0.002). Four of these markers also reached significance (p&lt;0.05) in APS versus PD analyses. Disease-specific analyses revealed lower group levels of FGF-5, FGF-19 and SPOCK1 in multiple system atrophy compared with progressive supranuclear palsy and corticobasal syndrome. Receiver operating characteristic curve analyses suggested that the diagnostic accuracy of NF-L was superior to the significant PEA biomarkers in distinguishing APS, PD and controls. The biological processes regulated by the significant proteins include cell differentiation and immune cell migration. Delta and notch-like epidermal growth factor-related receptor (DNER) had the strongest effect size in APS versus controls and APS versus PD analyses. DNER is highly expressed in substantia nigra and is an activator of the NOTCH1 pathway which has been implicated in the aetiology of other neurodegenerative disorders including Alzheimer\u2019s disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>PEA testing has identified potential novel diagnostic biomarkers of APS.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2018-320151","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T21:25:15Z","timestamp":1552512315000},"page":"768-773","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":52,"title":["Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes"],"prefix":"10.1136","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6844-882X","authenticated-orcid":false,"given":"Edwin","family":"Jabbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Woodside","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia K","family":"Magdalinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viorica","family":"Chelban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilan","family":"Athauda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Foltynie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele TM","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7216-8679","authenticated-orcid":false,"given":"James B","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huw R","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"key":"2024120416214230000_90.7.768.1","first-page":"1117","article-title":"Diagnostic approach to atypical parkinsonian syndromes","volume":"22","author":"McFarland","year":"2016","journal-title":"Continuum"},{"key":"2024120416214230000_90.7.768.2","doi-asserted-by":"crossref","unstructured":"Dam T , Boxer A , Golbe LI , et al . Efficacy and safety of BIIB092 in patients with progressive supranuclear palsy: PASSPORT phase 2 study design. Neurology 2018;90.","DOI":"10.1212\/WNL.90.15_supplement.P6.073"},{"key":"2024120416214230000_90.7.768.3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309562"},{"key":"2024120416214230000_90.7.768.4","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.1654"},{"key":"2024120416214230000_90.7.768.5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NFL: a biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"2024120416214230000_90.7.768.6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/acn3.325","article-title":"Neurofilament light chain: a biomarker for genetic frontotemporal dementia","volume":"3","author":"Meeter","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"2024120416214230000_90.7.768.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex pea immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"key":"2024120416214230000_90.7.768.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193278","article-title":"Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury","volume":"13","author":"Lagerstedt","year":"2018","journal-title":"PLoS One"},{"key":"2024120416214230000_90.7.768.9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/prca.201400130","article-title":"ELISA in the multiplex era: potentials and pitfalls","volume":"9","author":"Tighe","year":"2015","journal-title":"Prot. Clin. Appl."},{"key":"2024120416214230000_90.7.768.10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-318993"},{"key":"2024120416214230000_90.7.768.11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1474-4422(18)30232-1","article-title":"The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders","volume":"17","author":"Carmona","year":"2018","journal-title":"Lancet Neurol"},{"key":"2024120416214230000_90.7.768.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31585-4"},{"key":"2024120416214230000_90.7.768.13","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26987"},{"key":"2024120416214230000_90.7.768.14","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780090710"},{"key":"2024120416214230000_90.7.768.15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.221853"},{"key":"2024120416214230000_90.7.768.16","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26054"},{"key":"2024120416214230000_90.7.768.17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182563bd0"},{"key":"2024120416214230000_90.7.768.18","doi-asserted-by":"publisher","DOI":"10.1038\/19083"},{"key":"2024120416214230000_90.7.768.19","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-315857"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2018-320151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:22:26Z","timestamp":1733358146000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2018-320151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":19,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,6,13]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1136\/jnnp-2018-320151"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2018-320151","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]}}}